Orasure management always intentionally guides very low so they can easily beat earnings and collect 100% of their "performance bonus" stock awards and cash bonus. It's a scam to steal from shareholders who keep waiting for the HIV/OTC test bonanza. Someday that may happen, but it's been so many years in coming that it's benefit is now diminished as better HIV drug treatments are available and HIV/AIDS is far removed from daily news headlines. As always with this company, expect delays. The only good thing here is that the stock is so boring that momentum daytraders have ignored it and thus there is almost no significant downside pressure.